Projecting the impact of the 1976 Medical Device Amendments on innovation in clinical chemistry tests

This paper is concerned with the impact of the Medical Device Amendments of 1976 and its implications in terms of innovation. With this objective the paper first describes the Medical Device Amendments of 1976. The paper then reports empirical evidence on the sources of a subset of innovations regulated by the Amendment's clinical chemistry diagnostic products. Finally, based on the pattern of innovations found, some thoughts are expressed about the likely effects of the Amendments.     

Improve Toolmarks' Impressions in Soft Wax

When the forensic toolmarks laboratory receives for examination and comparison a tool that is suspected of having been involved in a crime, the expert performs tests designed to determine whether or not the specific tool generates the same toolmarks as those found at the crime scene. This is performed by testing tool striation on a piece of soft metal, such as lead, and examining the marks left by the tool. Studies have shown that wax may be an optimal material for this purpose. This study examines the use of wax at different temperatures and shows that quality of results is better when the wax is cooled (recommended temperature is ?18°C). At this temperature, the wax is flexible enough but does not smear and is not sticky. This makes the obtained marks clearer and of better quality.     

Foetal politics and the birth of an industry

In early Western society, women were considered to have a minor role in the reproductive process. Their social status was, correspondingly, secondary. Since the eighteenth century, women's contribution to procreation has been widely accepted, yet their social status remains. Women's importance in the reproduction of the species has not guaranteed them social prestige and the argument of this paper is that women's social standing is being further assaulted by the legal and economic consequences of innovations in birth technology. Two well-publicized innovations, Artificial Insemination by Donor, and In-Vitro Fertilization (or ‘test-tube babies’) have provoked legal, political and economic considerations which focus upon the possibilities of extensive bioengineering. The significance of this for women is that birth technology is not being fashioned after the interests of its clients but, instead, is becoming a new mercantile frontier in which women's needs may well be eclipsed by commercial and political ambitions.